← Back to Patent Explorer
US3856934A Expired / Lapsed US ⏱️ 0.0 years remaining

Skin depigmentation

Assignee: Individual
•
Filing: 1973-01-22
•
Granted: 1974-12-24
•
Expires: 1993-01-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The specification discloses that synergistic compositions for depigmentation by topical application have been found which comprise a mixture of hydroquinone, retinoic acid and a corticosteroid formulated in a pharmaceutically-cosmetically acceptable vehicle. An illustrative composition comprising from about 2 percent to about 5 percent hydroquinone, from about 0.05 percent to about 0.1 percent retinoic acid and from about 0.05 percent to about 0.1 percent dexamethasone was particularly effective.

Inventors

  • 👤 A Kligman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:55
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/33; A61K8/36; A61K8/361; A61K8/34; A61K8/347; A61K8/368; A61K8/37; A61K8/40; A61K8/41; A61K8/46; A61K8/463; A61K8/466; A61K8/63; A61K8/67; A61K8/671; A61K8/69; A61K8/72; A61K8/84; A61K8/86; A61Q; A61Q19/00; A61Q19/02

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 22 words
A SKIN DEPIGMENTING COMPOSITION FOR TOPICAL APPLICATION TO THE SKIN COMPRISING A MELANIN INHIBITING AMOUNT OF HYDROQUINONE, RETINOIC ACID AND A CORTICOSTEROID.
Claim 2
Dependent Claim 22 words
A SKIN DEPIGMENTING COMPOSITION FOR TOPICAL APPLICATION TO THE SKIN COMPRISING A MELANIN INHIBITING AMOUNT OF HYDROQUINONE, RETINOIC ACID AND A CORTICOSTEROID.
Claim 3
Dependent Claim 29 words
A composition according to claim 1 comprising a melanin inhibiting amount of hydroquinone, retinoic acid, and a corticosteroid selected from the group consisting of dexamethasone, hydrocortisone, hydrocortisone-17-valerate, and progesterone.
Claim 4
Dependent Claim 45 words
The composition of claim 2 consisting essentially of from about 2 to about 5 weight percent hydroquinone, from about 0.05 to about 0.1 weight percent retinoic acid, and from about 0.05 to about 0.1 weight percent dexamethasone in a pharmaceutically acceptable vehicle for topical application.
Claim 5
Dependent Claim 46 words
A composition according to claim 2 consisting essentially of from about 2 to about 5 weight percent hydroquinone, from about 0.05 to about 0.1 weight percent hydrocortisone-17-valerate, and from about 0.05 to about 0.1 weight percent retinoic acid in a pharmaceutically acceptable vehicle for topical application.
Claim 6
Independent Claim 28 words
A method for inhibiting the production of melanin which comprises topical application of a composition comprising hydroquinone, retinoic acid, and a corticosteroid, in amounts sufficient to cause depigmentation.
Claim 7
Independent Claim 28 words
A method for inhibiting the production of melanin which comprises topical application of a composition comprising hydroquinone, retinoic acid, and a corticosteroid, in amounts sufficient to cause depigmentation.
Claim 8
Dependent Claim 16 words
The method of claim 5 wherein said composition consists essentially of hydroquinone, retinoic acid, and dexamethasone.
Claim 9
Dependent Claim 62 words
A method according to claim 5 which comprises topical application to pigmented skin of a composition comprising from about 2 to about 5 weight percent hydroquinone, from about 0.05 to about 0.1 weight percent retinoic acid, and from about 0.05 to about 0.1 weight percent hydrocortisone-17-valerate in a pharmaceutically acceptable vehicle for Topical application and continuing such application until depigmentation is achieved.
Claim 10
Dependent Claim 54 words
A method according to claim 5 which comprises topical application to pigmented skin of a composition comprising from about 2 to about 5 weight percent hydroquinone, from about 0.05 to about 0.1 weight percent retinoic acid, and from about 0.05 to about 0.1 weight percent dexamethasone in a pharmaceutically acceptable vehicle for topical application.

References Cited (Backward Citations)

US3006939A Cited
US3060097A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-12-23 1978-06-24 1978-12-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-12-23 1982-06-24 1982-12-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-12-23 1986-06-24 1986-12-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag